Literature DB >> 20364303

Recent incarceration linked to cutaneous injection-related infections among active injection drug users in a Canadian setting.

M-J Milloy1, Evan Wood, Elisa Lloyd-Smith, Eric Grafstein, Mark Tyndall, Julio Montaner, Thomas Kerr.   

Abstract

Cutaneous injection-related infections (CIRI), such as abscesses and cellulitis, are the cause of a substantial burden of morbidity and mortality among injection drug users (IDU). The possible contribution of exposure to correctional environments to CIRI risk has not been fully investigated. Thus, we sought to test the possible relationship between incarceration and CIRI using data from a community-based sample of IDU. Data for these analyses was from the Scientific Evaluation of Supervised Injecting (SEOSI) cohort, linked with administrative records of a local ED in Vancouver, Canada. Using longitudinal analysis we assessed the relationship between the number of ED visits for CIRI care and recent incarceration in a multivariate model including information on possible confounders. Between June 2004 and December 2006, 901 individuals were eligible for our analysis. Of these, 214 (9.6%) visited the ED for CIRI care at least once during the study period. The incidence of ED care for CIRI was 72.9 per 100 person years. In a multivariate model, recent incarceration was associated with a greater number of ED visits for CIRI care (adjusted relative rate = 1.56, 95% confidence interval: 1.31-1.85, P < 0.001). The need for ED treatment for CIRI was common among a sample of local IDU. Exposure to correctional environments was an independent risk factor for visiting the ED for CIRI care, suggesting improvements in infection control in local prisons is urgently needed.

Entities:  

Mesh:

Year:  2010        PMID: 20364303     DOI: 10.1007/s10900-010-9269-y

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  39 in total

1.  High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco.

Authors:  I A Binswanger; A H Kral; R N Bluthenthal; D J Rybold; B R Edlin
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

2.  Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails.

Authors:  Erica S Pan; Binh A Diep; Heather A Carleton; Edwin D Charlebois; George F Sensabaugh; Barbara L Haller; Françoise Perdreau-Remington
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

3.  High rates of primary care and emergency department use among injection drug users in Vancouver.

Authors:  T Kerr; E Wood; E Grafstein; T Ishida; K Shannon; C Lai; J Montaner; M W Tyndall
Journal:  J Public Health (Oxf)       Date:  2004-11-25       Impact factor: 2.341

4.  Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison.

Authors:  Will Small; S Kain; Nancy Laliberte; Martin T Schechter; Michael V O'Shaughnessy; Patricia M Spittal
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

5.  Do supervised injecting facilities attract higher-risk injection drug users?

Authors:  Evan Wood; Mark W Tyndall; Kathy Li; Elisa Lloyd-Smith; Will Small; Julio S G Montaner; Thomas Kerr
Journal:  Am J Prev Med       Date:  2005-08       Impact factor: 5.043

6.  Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later.

Authors:  G N Al-Rawahi; A G Schreader; S D Porter; D L Roscoe; R Gustafson; E A Bryce
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

Review 7.  Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies.

Authors:  S Bassetti; M Battegay
Journal:  Infection       Date:  2004-06       Impact factor: 3.553

8.  Prevalence of USA300 colonization or infection and associated variables during an outbreak of community-associated methicillin-resistant Staphylococcus aureus in a marginalized urban population.

Authors:  Mark Gilbert; Judy Macdonald; Marie Louie; Dan Gregson; Kunyan Zhang; Sameer Elsayed; Kevin Laupland; Diane Nielsen; Virginia Wheeler; Tara Lye; John Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-11       Impact factor: 2.471

9.  The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART.

Authors:  Viviane D Lima; Josie Geller; David R Bangsberg; Thomas L Patterson; Mark Daniel; Thomas Kerr; Julio S G Montaner; Robert S Hogg
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

10.  Quasi-Poisson vs. negative binomial regression: how should we model overdispersed count data?

Authors:  Jay M Ver Hoef; Peter L Boveng
Journal:  Ecology       Date:  2007-11       Impact factor: 5.499

View more
  1 in total

1.  Drug Injection to Sites other than Arm: A Study of Iranian Heroin Injectors.

Authors:  Mehrdad Karimi; Hafez Ghaheri; Shervin Assari; Khodabakhsh Ahmadi; Maryam Moghani Lankarani; Reza Moghani Lankarani; Hooman Narenjiha; Hassan Rafiey; Mahmood Tavakoli; Firoozeh Jafari
Journal:  Front Psychiatry       Date:  2014-04-07       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.